Treatment of anaphylactic shock: Where is the evidence?

Anesthesia and Analgesia

Volumn 107, Issue 2, 2008, Pages 359-361

  Dünser, Martin W ^a   Torgersen, Christian ^a   Wenzel, Volker ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; ARGIPRESSIN; CATECHOLAMINE; CORTICOSTEROID; HISTAMINE H1 RECEPTOR ANTAGONIST; VASOCONSTRICTOR AGENT;

ANAPHYLACTIC SHOCK; ANAPHYLAXIS; CARDIOVASCULAR FUNCTION; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; EVIDENCE BASED MEDICINE; FLUID RESUSCITATION; FORWARD HEART FAILURE; HEART FAILURE; HUMAN; PRIORITY JOURNAL; SHOCK; SKIN ALLERGY; TACHYCARDIA; NOTE;

ANAPHYLAXIS; ARGININE VASOPRESSIN; EPINEPHRINE; EVIDENCE-BASED MEDICINE; HUMANS; VASOCONSTRICTOR AGENTS;

EID: 49949113544     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181753253     Document Type: Editorial

References (14)

1. Schummer C, Wirsing M, Schummer W. The pivotal role of vasopressin in refractory anaphylactic shock. Anesth Analg 2008;107:620-4
2. Soar J, Deakin CD, Nolan JP, Abbas G, Alfonzo A, Handley AJ, Lockey D, Perkins GD, Thies K. European Resuscitation Council Guidelines for Resuscitation 2005-Section 7. Cardiac arrest in special circumstances. Resuscitation 2005;67(suppl 1):S135-70
3. Centre for evidence-based medicine: levels of evidence and grades of recommendation. Available at: http://www.cebm.net/levels-of-evidence.asp. Accessed April 25, 2008.
4. Sheikh A, Ten Broek V, Brown SG, Simons FE. H1-antihistamines for the treatment of anaphylaxis: cochrane systematic review. Allergy 2007;62:830-7
5. Brown SG. The pathophysiology of shock in anaphylaxis. Immunol Allergy Clin North Am 2007;27:165-75
6. Pumphrey R. Anaphylactic shock. In: Paradis NA, Halperin HR, Kern KB, Wenzel V, Chamberlain DA, eds. Cardiac arrest-the science and practice of resuscitation medicine. Cambridge, United Kingdom: Cambridge University Press, 2007:1103-17
7. Luckner G, Dü nser MW, Jochberger S, Mayr VD, Wenzel V, Ulmer H, Schmid S, Knotzer H, Pajk W, Hasibeder WR, Mayr AJ, Friesenecker B. Arginine vasopressin in 316 patients with advanced vasodilatory shock. Crit Care Med 2005;33:2659-66
8. Dü nser MW, Mayr AJ, Hanno U, Knotzer H, Sumann G, Pajk W, Friesenecker B, Hasibeder WR. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 2003;107:2313-19
9. Russell JA, Cooper DJ, Walley KR. Vasopressin and septic shock trial (VASST): baseline characteristics and organ dysfunction in vasopressor dependent patients with septic shock. Am J Respir Crit Care Med 2003;167:A548
10. McLean-Tooke APC, Bethune CA, Fay AC, Spickett GP. Adrenaline in the treatment of anaphylaxis: what is the evidence? BMJ 2003;327:1332-5
11. Tsuda A, Tanaka KA, Huraux C, Szlam F, Sato N, Yamaguchi K, Levy JH. The in vitro reversal of histamine-induced vasodilation in the human internal mammary artery. Anesth Analg 2001; 93:1453-9
12. Shelly MP, Greatorex R, Calne RY, Park GR. The physiological effects of vasopressin when used to control intra-abdominal bleeding. Intensive Care Med 1988;14:526-31
13. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson T, Townsend S, Vender JS, Zimmerman JL, Vincent JL; for the International Surviving Sepsis Campaign Guidelines Committee. Surviving sepsis campaign: international guidelines for management of severe sespsis and septic shock: 2008. Crit Care Med 2008;36:296 -327
14. Luckner G, Mayr VD, Jochberger S, Wenzel V, Ulmer H, Hasibeder WR, Dü nser MW. Comparison of two dose regimens of arginine vasopressin in advanced vasodilatory shock. Crit Care Med 2007;35:2280-5